5 years ago

EvoNetix Raises $30M for Gene Synthesis Platform

  • UK-based synthetic biology company Evonetix has closed a $30m Series B funding round led by Foresite Capital

  • The company will use the funds to accelerate internal technology development and increase headcount.

    • ProblemBiotechnology

      "scaling and accelerating the process of DNA synthesis for various industries"

      Solution

      "developing a desktop platform with a silicon chip that controls the synthesis of DNA in parallel, achieving high accuracy, speed, and scalability"

      Covered on